NASDAQ : PCRX
Pacira BioSciences, Inc. — Financial statements
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 36.39 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.45B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Pacira BioSciences, Inc. (PCRX) reported revenue of 746.16M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 746.16M | 726.41M | 700.97M | 674.98M | 666.82M | 541.53M |
| Cost of Revenue | 155.15M | 149.75M | 170.43M | 184.67M | 199.29M | 140.25M |
| Gross Profit | 591.01M | 576.66M | 530.54M | 490.31M | 467.53M | 401.28M |
| Selling, General & Admin | 379.16M | 368.76M | 294.10M | 269.44M | 254.52M | 199.34M |
| Research & Development | 121.73M | 117.31M | 81.58M | 76.26M | 84.80M | 55.55M |
| Amortization of Goodwill & Intangibles | 57.29M | 57.29M | 57.29M | 57.29M | 57.29M | 13.55M |
| Other Operating Expenses | 42.91M | |||||
| Operating Expenses | 558.18M | 543.36M | 432.96M | 402.99M | 396.60M | 311.35M |
| Operating Income | 32.83M | 33.30M | 97.57M | 87.32M | 70.93M | 89.92M |
| Interest Expense | -15.49M | -17.45M | -16.57M | -20.31M | -39.98M | -31.75M |
| Interest & Investment Income | 14.70M | 22.73M | 19.69M | 11.44M | 4.54M | 896.00K |
| Other Non Operating Income (Expenses) | -8.84M | -10.81M | -373.00K | -186.00K | -1.29M | -66.00K |
| EBT Excluding Unusual Items | 23.20M | 27.78M | 100.32M | 78.28M | 34.20M | 59.00M |
| Merger & Restructuring Charges | -4.07M | -6.57M | -9.99M | -3.07M | -11.24M | |
| Impairment of Goodwill | -163.24M | |||||
| Gain (Loss) on Sale of Investments | 8.39M | 4.19M | -10.00M | -2.60M | ||
| Asset Writedown | -25.87M | -25.87M | -26.13M | |||
| Legal Settlements | 23.15M | 16.15M | ||||
| Other Unusual Items | -1.23M | 1.19M | 9.81M | -13.50M | 26.48M | |
| Pretax Income | 17.65M | 16.87M | -63.11M | 61.70M | 13.30M | 56.40M |
| Income Tax Expense | 3.01M | 9.84M | 36.45M | 19.75M | -2.61M | 14.42M |
| Net Income | 14.64M | 7.03M | -99.56M | 41.95M | 15.91M | 41.98M |
| Net Income to Common | 14.64M | 7.03M | -99.56M | 41.95M | 15.91M | 41.98M |
| Shares Outstanding (Basic) | 41.61M | 44.57M | 46.24M | 46.22M | 45.52M | 44.26M |
| Shares Outstanding (Diluted) | 42.41M | 45.04M | 46.24M | 51.98M | 46.54M | 45.63M |
| EPS (Basic) | 0.35 | 0.16 | -2.15 | 0.91 | 0.35 | 0.95 |
| EPS (Diluted) | 0.35 | 0.16 | -2.15 | 0.89 | 0.34 | 0.92 |
| Free Cash Flow | 179.51M | 136.66M | 178.75M | 139.49M | 115.20M | 79.85M |
| Free Cash Flow Per Share | 4.23 | 3.03 | 3.87 | 2.68 | 2.48 | 1.75 |
| Gross Margin | 79.21% | 79.38% | 75.69% | 72.64% | 70.11% | 74.10% |
| Operating Margin | 4.40% | 4.58% | 13.92% | 12.94% | 10.64% | 16.61% |
| Profit Margin | 1.96% | 0.97% | -14.20% | 6.22% | 2.39% | 7.75% |
| Free Cash Flow Margin | 24.06% | 18.81% | 25.50% | 20.67% | 17.28% | 14.74% |
| EBITDA | 123.97M | 124.33M | 176.36M | 162.90M | 151.93M | 118.47M |
| EBITDA Margin | 16.61% | 17.11% | 25.16% | 24.13% | 22.78% | 21.88% |
| D&A For EBITDA | 91.14M | 91.02M | 78.78M | 75.57M | 81.00M | 28.55M |
| EBIT | 32.83M | 33.30M | 97.57M | 87.32M | 70.93M | 89.92M |
| EBIT Margin | 4.40% | 4.58% | 13.92% | 12.94% | 10.64% | 16.61% |
| Effective Tax Rate | 17.06% | 58.31% | 32.00% | 25.57% | ||
| Revenue as Reported | 746.16M | 726.41M | 700.97M | 674.98M | 666.82M | 541.53M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 205.88M | 158.54M | 276.77M | 153.30M | 104.14M | 585.58M |
| Short-Term Investments | 45.16M | 79.88M | 207.84M | 125.28M | 184.51M | 70.83M |
| Cash & Short-Term Investments | 251.03M | 238.42M | 484.62M | 278.58M | 288.65M | 656.41M |
| Accounts Receivable | 132.42M | 124.07M | 113.30M | 105.56M | 98.40M | 96.32M |
| Other Receivables | 8.60M | 300.00K | 500.00K | 400.00K | 800.00K | 100.00K |
| Receivables | 141.02M | 124.37M | 113.80M | 105.96M | 99.20M | 96.42M |
| Inventory | 134.57M | 152.86M | 125.28M | 104.35M | 96.06M | 98.55M |
| Prepaid Expenses | 21.25M | 30.62M | 20.43M | 20.40M | 14.32M | 14.67M |
| Other Current Assets | 67.34M | 1.70M | 1.00M | 700.00K | 100.00K | |
| Total Current Assets | 615.22M | 547.97M | 745.13M | 509.99M | 498.33M | 866.05M |
| Property, Plant & Equipment | 175.20M | 182.47M | 216.39M | 234.95M | 254.39M | 264.81M |
| Long-Term Investments | 7.75M | 16.31M | 29.45M | 32.26M | 60.18M | 21.99M |
| Goodwill | 19.64M | 20.21M | 163.24M | 163.24M | 145.18M | |
| Other Intangible Assets | 285.48M | 368.10M | 425.97M | 483.26M | 540.55M | 623.97M |
| Long-Term Deferred Tax Assets | 124.60M | 123.85M | 130.38M | 144.49M | 160.31M | 153.36M |
| Other Long-Term Assets | 13.59M | 6.00M | 6.20M | 6.20M | 4.20M | |
| Total Assets | 1.24B | 1.26B | 1.55B | 1.57B | 1.68B | 2.08B |
| Accounts Payable | 17.51M | 15.15M | 19.13M | 15.70M | 15.22M | 10.54M |
| Accrued Expenses | 80.82M | 84.05M | 69.52M | 55.72M | 82.49M | 118.60M |
| Current Portion of Long-Term Debt | 201.78M | 8.64M | 33.65M | 374.70M | ||
| Current Portion of Leases | 10.30M | 9.84M | 8.89M | 8.80M | 9.12M | 7.89M |
| Current Income Taxes Payable | 429.00K | |||||
| Other Current Liabilities | 13.39M | 11.55M | 10.61M | 8.53M | 7.29M | 8.95M |
| Total Current Liabilities | 122.01M | 120.59M | 309.92M | 97.38M | 147.77M | 521.12M |
| Long-Term Debt | 363.12M | 372.19M | 383.55M | 513.80M | 655.82M | 674.53M |
| Long-Term Leases | 38.70M | 36.18M | 44.65M | 54.81M | 64.80M | 71.73M |
| Long-Term Deferred Tax Liabilities | 4.07M | 4.21M | ||||
| Other Long-Term Liabilities | 44.10M | 38.64M | 37.06M | 38.27M | 37.79M | 77.57M |
| Total Liabilities | 572.00M | 571.81M | 775.17M | 704.26M | 906.19M | 1.34B |
| Common Stock | 49.00K | 48.00K | 47.00K | 46.00K | 46.00K | 45.00K |
| Additional Paid-In Capital | 1.09B | 1.06B | 1.01B | 976.63M | 924.10M | 942.09M |
| Retained Earnings | -191.75M | -199.32M | -206.36M | -106.80M | -148.75M | -211.90M |
| Treasury Stock | -227.01M | -176.56M | -25.12M | |||
| Comprehensive Income & Other | 3.24M | 4.33M | 343.00K | 247.00K | -380.00K | 167.00K |
| Shareholders' Equity | 671.98M | 693.11M | 778.35M | 870.13M | 775.01M | 730.41M |
| Total Liabilities & Equity | 1.24B | 1.26B | 1.55B | 1.57B | 1.68B | 2.08B |
| Total Debt | 412.12M | 418.20M | 638.85M | 586.04M | 763.39M | 1.13B |
| Net Cash (Debt) | -161.09M | -179.78M | -154.24M | -307.46M | -474.74M | -472.44M |
| Net Cash Per Share | -3.80 | -3.99 | -3.34 | -5.92 | -10.20 | -10.35 |
| Filing Date Shares Outstanding | 39.86M | 40.49M | 46.28M | 46.50M | 45.95M | 44.85M |
| Total Common Shares Outstanding | 39.82M | 41.12M | 46.24M | 46.48M | 45.93M | 44.73M |
| Working Capital | 493.20M | 427.38M | 435.21M | 412.61M | 350.56M | 344.93M |
| Book Value Per Share | 16.87 | 16.86 | 16.83 | 18.72 | 16.87 | 16.33 |
| Tangible Book Value | 366.85M | 304.80M | 352.38M | 223.63M | 71.22M | -38.73M |
| Tangible Book Value Per Share | 9.21 | 7.41 | 7.62 | 4.81 | 1.55 | -0.87 |
| Machinery | 191.92M | 191.46M | 186.07M | 141.50M | 136.46M | 133.34M |
| Construction In Progress | 11.58M | 9.48M | 28.00M | 105.91M | 103.23M | 80.56M |
| Leasehold Improvements | 77.65M | 77.45M | 86.03M | 61.83M | 61.30M | 59.74M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 14.64M | 7.03M | -99.56M | 41.95M | 15.91M | 41.98M |
| Depreciation & Amortization | 91.14M | 91.02M | 78.78M | 75.57M | 81.00M | 28.55M |
| Other Amortization | 2.41M | 3.00M | 3.22M | 3.75M | 7.21M | 25.91M |
| Asset Writedown & Restructuring Costs | 20.37M | 25.87M | 163.24M | 36.63M | ||
| Loss (Gain) From Sale of Investments | -2.41M | 6.07M | -7.42M | -4.58M | 10.00M | |
| Stock-Based Compensation | 55.97M | 57.50M | 51.17M | 47.90M | 48.09M | 42.25M |
| Other Operating Activities | 5.17M | -235.00K | 11.05M | 31.25M | -37.14M | 12.55M |
| Change in Accounts Receivable | -21.77M | -10.74M | -7.75M | -7.16M | -2.08M | -10.43M |
| Change in Inventory | 3.75M | -27.57M | -20.93M | -8.29M | 2.49M | -4.47M |
| Change in Accounts Payable | -12.69M | -5.60M | 3.08M | 916.00K | 6.27M | -10.26M |
| Change in Other Net Operating Assets | 31.09M | 5.64M | 14.49M | -26.67M | -23.11M | -346.00K |
| Operating Cash Flow | 187.66M | 151.99M | 189.39M | 154.65M | 145.27M | 125.72M |
| Capital Expenditures | -8.15M | -15.33M | -10.64M | -15.16M | -30.08M | -45.87M |
| Cash Acquisitions | -335.00K | -16.70M | -32.00M | -424.04M | ||
| Investment in Securities | 102.63M | 131.52M | -72.64M | 92.70M | -163.11M | 449.12M |
| Investing Cash Flow | 94.15M | 99.48M | -83.28M | 77.54M | -225.19M | -20.79M |
| Long-Term Debt Issued | 101.00M | 287.50M | 149.55M | 363.75M | ||
| Long-Term Debt Repaid | -317.80M | -210.88M | -330.31M | -427.69M | ||
| Net Debt Issued (Repaid) | -220.24M | -216.80M | 76.61M | -180.76M | -427.69M | 363.75M |
| Issuance of Common Stock | 3.92M | 3.30M | 2.30M | 4.75M | 27.34M | 26.66M |
| Repurchase of Common Stock | -157.67M | -153.94M | -25.49M | -106.00K | ||
| Other Financing Activities | -2.19M | -2.19M | -36.06M | -6.91M | -1.18M | -9.71M |
| Financing Cash Flow | -376.18M | -369.63M | 17.36M | -183.03M | -401.53M | 380.69M |
| Foreign Exchange Rate Adjustments | -243.00K | -77.00K | ||||
| Net Cash Flow | -94.61M | -118.23M | 123.48M | 49.16M | -481.44M | 485.62M |
| Free Cash Flow | 179.51M | 136.66M | 178.75M | 139.49M | 115.20M | 79.85M |
| Free Cash Flow Margin | 24.06% | 18.81% | 25.50% | 20.67% | 17.28% | 14.74% |
| Free Cash Flow Per Share | 4.23 | 3.03 | 3.87 | 2.68 | 2.48 | 1.75 |
| Levered Free Cash Flow | 98.34M | 108.56M | 163.38M | 107.15M | 92.00M | 49.79M |
| Unlevered Free Cash Flow | 105.61M | 116.47M | 170.52M | 116.09M | 109.78M | 43.72M |
| Cash Interest Paid | 13.72M | 15.23M | 15.42M | 27.64M | 33.30M | 7.00M |
| Cash Income Tax Paid | 1.69M | 9.01M | 11.00M | 4.40M | 7.40M | 3.22M |
| Change in Working Capital | 379.00K | -38.27M | -11.10M | -41.20M | -16.43M | -25.51M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 1.45B | 1.11B | 869.90M | 1.57B | 1.77B | 2.68B |
| Enterprise Value | 1.61B | 1.29B | 1.06B | 1.92B | 2.26B | 2.54B |
| Last Close Price | 36.39 | 25.88 | 18.84 | 33.74 | 38.61 | 60.17 |
| PE Ratio | 103.45 | 158.29 | 37.34 | 111.35 | 63.85 | |
| Forward PE | 11.78 | 7.53 | 7.10 | 10.23 | 11.63 | 15.43 |
| PS Ratio | 1.94 | 1.53 | 1.24 | 2.32 | 2.66 | 4.95 |
| PB Ratio | 2.16 | 1.61 | 1.12 | 1.80 | 2.29 | 3.67 |
| P/TBV Ratio | 3.96 | 3.65 | 2.47 | 7.01 | 24.87 | |
| P/FCF Ratio | 8.08 | 8.15 | 4.87 | 11.23 | 15.38 | 33.57 |
| P/OCF Ratio | 7.73 | 7.33 | 4.59 | 10.13 | 12.19 | 21.32 |
| PEG Ratio | 1.18 | 0.54 | 0.54 | 0.54 | 0.53 | 0.66 |
| EV/Sales Ratio | 2.16 | 1.78 | 1.51 | 2.85 | 3.40 | 4.69 |
| EV/EBITDA Ratio | 13.01 | 10.39 | 6.01 | 11.80 | 14.90 | 21.45 |
| EV/EBIT Ratio | 49.11 | 38.81 | 10.87 | 22.01 | 31.93 | 28.26 |
| EV/FCF Ratio | 8.98 | 9.46 | 5.93 | 13.78 | 19.66 | 31.82 |
| Debt / Equity Ratio | 0.61 | 0.60 | 0.82 | 0.67 | 0.98 | 1.55 |
| Debt / EBITDA Ratio | 2.97 | 3.00 | 3.33 | 3.28 | 4.55 | 8.54 |
| Debt / FCF Ratio | 2.30 | 3.06 | 3.57 | 4.20 | 6.63 | 14.14 |
| Net Debt / Equity Ratio | 0.24 | 0.26 | 0.20 | 0.35 | 0.61 | 0.65 |
| Net Debt / EBITDA Ratio | 1.30 | 1.45 | 0.88 | 1.89 | 3.12 | 3.99 |
| Net Debt / FCF Ratio | 0.90 | 1.32 | 0.86 | 2.20 | 4.12 | 5.92 |
| Asset Turnover | 0.54 | 0.52 | 0.45 | 0.41 | 0.35 | 0.32 |
| Inventory Turnover | 1.10 | 1.08 | 1.48 | 1.84 | 2.05 | 1.72 |
| Quick Ratio | 3.21 | 3.01 | 1.93 | 3.95 | 2.62 | 1.45 |
| Current Ratio | 5.04 | 4.54 | 2.40 | 5.24 | 3.37 | 1.66 |
| Return on Equity (ROE) | 2.05% | 0.96% | -12.08% | 5.10% | 2.11% | 6.22% |
| Return on Assets (ROA) | 1.48% | 1.48% | 3.90% | 3.35% | 2.36% | 3.36% |
| Return on Invested Capital (ROIC) | 3.21% | 1.54% | 9.25% | 4.89% | 5.78% | 7.27% |
| Return on Capital Employed (ROCE) | 2.90% | 2.90% | 7.80% | 5.90% | 4.60% | 5.80% |
| Earnings Yield | 0.97% | 0.63% | -11.45% | 2.68% | 0.90% | 1.57% |
| FCF Yield | 12.37% | 12.27% | 20.55% | 8.90% | 6.50% | 2.98% |
| Buyback Yield / Dilution | 7.82% | 2.60% | 11.03% | -11.69% | -1.99% | -4.46% |